• Title of article

    Efficacy and Side Effects of Deferiprone (L1 ) in Thalassemia Patients Not Compliant with Desferrioxamine

  • Author/Authors

    Taher، Mohammad Ali نويسنده , , F.M.Chamoun، نويسنده , , S.Koussa، نويسنده , , M.AbiSaad، نويسنده , , A.I.Khoriaty، نويسنده , , R.Neeman، نويسنده , , F.H.Mourad، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1999
  • Pages
    -172
  • From page
    173
  • To page
    0
  • Abstract
    Effective prevention, or treatment, of invasive fungal infection in the neutropenic patient has hitherto been unsatisfactory because of either an inadequate anti-fungal spectrum of the agent or important toxicity. ltraconazole is effective against a broad spectrum of the opportunistic pathogens seen in Europe and North America. Prior problems with absorption, e.g. in the marrow transplant recipient, have been overcome with the introduction of an oral solution and an i.v. preparation. The deliberations of an expert meeting held in June, 1998 include recommendations on which patient requires one of these new preparations based on clinical trials, the dose and route. Important drug interactions are also detailed.
  • Keywords
    DEFERIPRONE , Iron chelation , Thalassemia
  • Journal title
    Acta Haematologica
  • Serial Year
    1999
  • Journal title
    Acta Haematologica
  • Record number

    25506